Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Clinical trial NCT00867113 · COMPLETED
Trial details
- NCT number
- NCT00867113
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-22
- Primary completion
- 2016-12-20
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.